1173 related articles for article (PubMed ID: 18571105)
21. MenACWY-CRM, a novel quadrivalent glycoconjugate vaccine against Neisseria meningitidis for the prevention of meningococcal infection.
Pace D
Curr Opin Mol Ther; 2009 Dec; 11(6):692-706. PubMed ID: 20072946
[TBL] [Abstract][Full Text] [Related]
22. Neisseria meningitidis serogroup W-135 carriage among US travelers to the 2001 Hajj.
Dull PM; Abdelwahab J; Sacchi CT; Becker M; Noble CA; Barnett GA; Kaiser RM; Mayer LW; Whitney AM; Schmink S; Ajello GW; Dolan-Livengood J; Stephens DS; Cetron MS; Popovic T; Rosenstein NE
J Infect Dis; 2005 Jan; 191(1):33-9. PubMed ID: 15593000
[TBL] [Abstract][Full Text] [Related]
23. Influenza and meningococcal disease: lessons for travellers and government from 2 epidemic diseases.
Booy R; El Bashir H; Rashid H; Shingadia D; Haworth E
Travel Med Infect Dis; 2009 Jul; 7(4):253-6. PubMed ID: 19717110
[TBL] [Abstract][Full Text] [Related]
24. Meningococcal B vaccine: new drug. The only vaccine against some serogroup B meningococci.
Prescrire Int; 2008 Jun; 17(95):95-7. PubMed ID: 18623907
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of serogroup A meningococcal vaccines in Africa: a demonstration project.
Soriano-Gabarró M; Rosenstein N; LaForce FM
J Health Popul Nutr; 2004 Sep; 22(3):275-85. PubMed ID: 15609780
[TBL] [Abstract][Full Text] [Related]
26. [Meningococcal vaccines: from polysaccharide to conjugate vaccines].
Cohen R; Levy C
Arch Pediatr; 2012 Sep; 19 Suppl 2():S61-4. PubMed ID: 22883368
[TBL] [Abstract][Full Text] [Related]
27. Quadrivalent meningococcal ACYW-135 glycoconjugate vaccine for broader protection from infancy.
Pace D
Expert Rev Vaccines; 2009 May; 8(5):529-42. PubMed ID: 19397410
[TBL] [Abstract][Full Text] [Related]
28. Quadrivalent meningococcal vaccines: hyporesponsiveness as an important consideration when choosing between the use of conjugate vaccine or polysaccharide vaccine.
Bröker M; Veitch K
Travel Med Infect Dis; 2010 Jan; 8(1):47-50. PubMed ID: 20188306
[TBL] [Abstract][Full Text] [Related]
29. Meningococcal vaccines.
Collins CL; Pollard AJ
Curr Opin Investig Drugs; 2002 Jul; 3(7):975-9. PubMed ID: 12186274
[TBL] [Abstract][Full Text] [Related]
30. Neisseria meningitidis serogroups A and W-135: carriage and immunity in Burkina Faso, 2003.
Mueller JE; Yaro S; Traore Y; Sangare L; Tarnagda Z; Njanpop-Lafourcade BM; Borrow R; Gessner BD
J Infect Dis; 2006 Mar; 193(6):812-20. PubMed ID: 16479516
[TBL] [Abstract][Full Text] [Related]
31. Meningococcal disease: the advances and challenges of meningococcal disease prevention.
Yogev R; Tan T
Hum Vaccin; 2011 Aug; 7(8):828-37. PubMed ID: 21832882
[TBL] [Abstract][Full Text] [Related]
32. Risk for meningococcal disease associated with the Hajj 2001.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2001 Feb; 50(6):97-8. PubMed ID: 11263795
[TBL] [Abstract][Full Text] [Related]
33. The epidemiology of meningococcal disease and the impact of vaccines.
Khatami A; Pollard AJ
Expert Rev Vaccines; 2010 Mar; 9(3):285-98. PubMed ID: 20218857
[TBL] [Abstract][Full Text] [Related]
34. Meningococcal carriage in Umra pilgrims returning from Saudi Arabia.
Wilder-Smith A; Paton NI; Barkham TM; Earnest A
J Travel Med; 2003; 10(3):147-9. PubMed ID: 12757687
[TBL] [Abstract][Full Text] [Related]
35. Prevention of meningococcal disease: current use of polysaccharide and conjugate vaccines.
Poland GA
Clin Infect Dis; 2010 Mar; 50 Suppl 2():S45-53. PubMed ID: 20144016
[TBL] [Abstract][Full Text] [Related]
36. Serogroup B meningococcal vaccines.
Zimmer SM; Stephens DS
Curr Opin Investig Drugs; 2006 Aug; 7(8):733-9. PubMed ID: 16955685
[TBL] [Abstract][Full Text] [Related]
37. Meningococcal vaccines: a neglected topic in travel medicine?
Wilder-Smith A
Expert Rev Vaccines; 2009 Oct; 8(10):1343-50. PubMed ID: 19803757
[TBL] [Abstract][Full Text] [Related]
38. Epidemiology and prevention of meningococcal disease: a critical appraisal of vaccine policies.
Sáfadi MA; McIntosh ED
Expert Rev Vaccines; 2011 Dec; 10(12):1717-30. PubMed ID: 22085175
[TBL] [Abstract][Full Text] [Related]
39. Hajj-associated outbreak strain of Neisseria meningitidis serogroup W135: estimates of the attack rate in a defined population and the risk of invasive disease developing in carriers.
Wilder-Smith A; Goh KT; Barkham T; Paton NI
Clin Infect Dis; 2003 Mar; 36(6):679-83. PubMed ID: 12627350
[TBL] [Abstract][Full Text] [Related]
40. [Tetravalent anti-meningococcal vaccine: serologic and clinical evaluation].
Vescia N; Mastroeni I; Pompa MG; Signorelli C; Fara GM
Ann Ig; 1989; 1(6):1293-8. PubMed ID: 2484465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
